Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 98(9): 4904-9, 2001 Apr 24.
Article in English | MEDLINE | ID: mdl-11320241

ABSTRACT

The structures of the ligand-binding domains (LBD) of the wild-type androgen receptor (AR) and the T877A mutant corresponding to that in LNCaP cells, both bound to dihydrotestosterone, have been refined at 2.0 A resolution. In contrast to the homodimer seen in the retinoid-X receptor and estrogen receptor LBD structures, the AR LBD is monomeric, possibly because of the extended C terminus of AR, which lies in a groove at the dimerization interface. Binding of the natural ligand dihydrotestosterone by the mutant LBD involves interactions with the same residues as in the wild-type receptor, with the exception of the side chain of threonine 877, which is an alanine residue in the mutant. This structural difference in the binding pocket can explain the ability of the mutant AR found in LNCaP cells (T877A) to accommodate progesterone and other ligands that the wild-type receptor cannot.


Subject(s)
Dihydrotestosterone/metabolism , Mutation/genetics , Receptors, Androgen/chemistry , Receptors, Androgen/metabolism , Amino Acid Sequence , Amino Acid Substitution/genetics , Androgens , Animals , Binding Sites , Crystallography, X-Ray , Dihydrotestosterone/chemistry , Dihydrotestosterone/pharmacology , Dimerization , Humans , Ligands , Male , Models, Molecular , Molecular Sequence Data , Progesterone/chemistry , Progesterone/metabolism , Prostatic Neoplasms/genetics , Protein Structure, Tertiary , Rats , Receptors, Androgen/genetics , Receptors, Progesterone/chemistry , Receptors, Progesterone/metabolism , Sequence Alignment , Substrate Specificity , Threonine/genetics , Threonine/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...